GL1X · GenesisL1 explorer

MolNFT v1 · #95613 · protein

JAK1 kinase (JH1 domain) in complex with the inhibitor trans-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)- YL}CYCLOHEXANECARBONITRILE

4IVB · Tyrosine-protein kinase JAK1: “JAK1 kinase (JH1 domain) in complex with the inhibitor trans-4-{2…”. X-ray diffraction, 1 ligand (1J5), 5 pockets (best druggability 0.74). MolNFT v1 #95613 on GenesisL1: 3D structure, binding sites…

PDB
4IVB
Type
protein
Length
575 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK1
EC
2.7.10.2
UniProt
P23458
Ligands
1J5
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK1 (EC 2.7.10.2)protein29341% helix, 18% strandP23458
BTyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28243% helix, 20% strandP23458

Ligands and binding sites

  • 1J5 · trans-4-{2-[(1R)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl}cyclohexanecarbonitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13690.740.85541J5
22750.650.82471J5
3680.430.8217empty
4700.300.7316empty
5500.240.7313empty

Interfaces

1 interface between chains.

  • A–B · 963 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 4IVB · JAK1 kinase (JH1 domain) in complex with the inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.